Clinical Trials Logo
  1. Home
  2. Brain Aneurysm
  3. NCT01716117

Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms — SCENT  

Brain Aneurysm Clinical Trial

Official title:
The Surpass Intracranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms (SCENT Trial)

Clinical Trial Summary

This clinical research study is designed to determine safety and effectiveness of the Surpass Flow Diverter (Surpass System), an investigational device developed to treat wide-neck, large or giant intracranial aneurysms. An intracranial aneurysm is a bulge in the wall of a blood vessel in the brain. The bulge is caused by a weakening of the vessel wall. If left untreated, the bulge may continue to grow larger and ultimately the vessel may break open (rupture), resulting in serious bleeding into or around the brain. The information collected from this study will be used to evaluate how well patients do when treated with the Surpass System both immediately after treatment of an aneurysm and over a long period of time (5 years).

Clinical Trial Description

The objective of this study is to determine safety and effectiveness of the Surpass Flow Diverter (Surpass System) in the endovascular treatment of large or giant wide-necked intracranial aneurysms in the internal carotid artery up to the terminus. The Surpass Flow Diverter is an intracranial implant designed to be placed in a parent artery so as to divert blood flow away from an aneurysm. Use of the Surpass System may be associated with a decrease in neurological death or ipsilateral stroke in patients with large or giant wide-neck aneurysms. In a given patient, the Surpass System will be deemed effective if treatment results in complete occlusion of their aneurysm without clinically significant stenosis of the parent artery, or requires retreatment of the aneurysm through 12 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01716117
Study type Interventional
Source Stryker Neurovascular
Contact
Status Completed
Phase N/A
Start date October 25, 2012
Completion date July 7, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02345395 - Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms N/A
Active, not recruiting NCT05626504 - Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
Completed NCT04553549 - Safety and Feasibility of the Infinity Catheter for Radial Access
Completed NCT04439760 - Superior Cervical Ganglion Block, Transcranial Doppler N/A
Completed NCT01975233 - WEB French Observatory of the WEB Aneurysm Embolization System
Terminated NCT01557036 - Aneurysm Study of Pipeline in an Observational Registry N/A
Completed NCT02435823 - Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial Aneurysms N/A
Completed NCT03844334 - CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms
Active, not recruiting NCT03852680 - Current Treatment Modalities for Wide Necked Intracranial Aneurysms N/A
Completed NCT01444664 - Aneurysm Wall Histology Registry Phase 4
Recruiting NCT03936647 - The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices N/A
Completed NCT02687607 - CLARYS: CLinical Assessment of WEB® Device in Ruptured aneurYSms
Withdrawn NCT02037932 - Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry Phase 4
Recruiting NCT06456814 - Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China
Recruiting NCT05317169 - Aneurysm Genetic Risk in Patients With QIB Changes
Terminated NCT00537134 - Trial on Endovascular Aneurysm Management N/A